Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 3, 2010, Pages

  English, Brett A ^a   Appalsamy, Martin ^a   Diedrich, Andre ^a   Ruggiero, Alicia M ^a   Lund, David ^a   Wright, Jane ^a   Keller, Nancy R ^a   Louderback, Katherine M ^a   Robertson, David ^a   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Autonomic nervous system; Echocardiography; Heart; Polymorphism

Indexed keywords

CARRIER PROTEIN; CHOLINE TRANSPORT PROTEIN; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; CHOLINE; CHT1 PROTEIN, RAT;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CHOLINERGIC NERVE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENETIC POLYMORPHISM; HEART MUSCLE FIBROSIS; HEART RATE; HEART VENTRICLE FAILURE; HYPERTENSION; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TACHYCARDIA; TELEMETRY; TRANSGENIC MOUSE; TREADMILL EXERCISE; VAGUS TONE; AGE; ANALYSIS OF VARIANCE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; BODY WEIGHT; CARDIOMEGALY; GENETICS; HEART VENTRICLE FUNCTION; METABOLISM; WESTERN BLOTTING;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; AUTONOMIC NERVOUS SYSTEM; BLOTTING, WESTERN; BODY WEIGHT; CARDIOMEGALY; CATION TRANSPORT PROTEINS; CHOLINE; ECHOCARDIOGRAPHY; HEART RATE; HYPERTENSION; MALE; MICE; MICE, TRANSGENIC; PHYSICAL CONDITIONING, ANIMAL; TACHYCARDIA; TELEMETRY; VENTRICULAR DYSFUNCTION;

EID: 77956706422     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00170.2010     Document Type: Article

References (70)

1. Apparsundaram S, Ferguson SM, Blakely RD. Molecular cloning and characterization of a murine hemicholinium-3-sensitive choline transporter. Biochem Soc Trans 29: 711-716, 2001. (Pubitemid 33131767)
2. Apparsundaram S, Ferguson SM, George AL Jr, Blakely RD. Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. Biochem Biophys Res Commun 276: 862-867, 2000.
3. Azevedo ER, Parker JD. Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. Circulation 100: 274-279, 1999.
4. Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW. Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 292: H2119-H2130, 2007.
5. Barron HV, Lesh MD. Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol 27: 1053-1060, 1996. (Pubitemid 26117693)
6. Bazalakova MH, Blakely RD. The high-affinity choline transporter: a critical protein for sustaining cholinergic signaling as revealed in studies of genetically altered mice. Handb Exp Pharmacol: 525-544, 2006.
7. Bazalakova MH, Wright J, Schneble EJ, McDonald MP, Heilman CJ, Levey AI, Blakely RD. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice. Genes Brain Behav 6: 411-424, 2007.
8. Bertrand N, Beley P, Beley A. Brain fixation for acetylcholine measurements. J Neurosci Methods 53: 81-85, 1994.
9. Binkley P. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 18: 464-472, 1991.
10. Brodde OE, Leineweber K. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur J Pharmacol 500: 167-176, 2004.
11. Brown AD, Barton DA, Lambert GW. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 23: 583-602, 2009.
12. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 283: H1838-H1845, 2002.
13. Chen Y, Chandler MP, DiCarlo SE. Acute exercise attenuates cardiac autonomic regulation in hypertensive rats. Hypertension 26: 676-683, 1995.
14. Cirillo M, Laurenzi M, Trevisan M, Stamler Hematocrit J, blood pressure, hypertension. The Gubbio Population Study. Hypertension 20: 319-326, 1992.
15. Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med 341: 1351-1357, 1999. (Pubitemid 29503574)
16. Collins KA, Korcarz CE, Lang RM. Use of echocardiography for the phenotypic assessment of genetically altered mice. Physiol Genomics 13: 227-239, 2003.
17. Damsma G, Westerink BH, Horn AS. A simple, sensitive, and economic assay for choline and acetylcholine using HPLC, an enzyme reactor, and an electrochemical detector. J Neurochem 45: 1649-1652, 1985.
18. 1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059-7064, 1999.
19. English BA, Hahn MK, Gizer IR, Mazei-Robinson M, Steele A, Kurnik DM, Stein MA, Waldman ID, Blakely RD. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J Neurodev Disorder. In press.
20. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci USA 101: 8762-8767, 2004.
21. Ferguson SM, Blakely RD. The choline transporter resurfaces: new roles for synaptic fesicles? Mol Interv 4: 22-37, 2004.
22. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23: 9697-9709, 2003.
23. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 20: 333-339, 1992.
24. 3 muscarinic acetylcholine receptors. FASEB J 18: 711-713, 2004.
25. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 50: 823-830, 2007.
26. Gava AL, Peotta VA, Cabral AM, Meyrelles SS, Vasquez EC. Decreased baroreflex sensitivity in isoproterenol-treated mice with cardiac hypertrophy. Auton Neurosci 114: 47-54, 2004.
27. Hahn MK, Blackford JU, Haman K, Mazei-Robison M, English BA, Prasad HC, Steele A, Hazelwood L, Fentress HM, Myers R, Blakely RD, Sanders-Bush E, Shelton R. Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav 7: 487-495, 2008.
28. Hoard JL, Hoover DB, Mabe AM, Blakely RD, Feng N, Paolocci N. Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75. Neuroscience 156: 129-142, 2008.
29. Huang KL, Su TP, Chen TJ, Chou YH, Bai YM. Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci 63: 401-409, 2009.
30. Hughes JW, York KM, Li Q, Freedland KE, Carney RM, Sheps DS. Depressive symptoms predict heart rate recovery after exercise treadmill testing in patients with coronary artery disease: results from the Psychophysiological Investigation of Myocardial Ischemia study. Psychosom Med 70: 456-460, 2008.
31. Iyer VR. Ventricular dysfunction: tachycardia induced cardiomyopathy. Indian Pacing Electrophysiol J 8: S122-S129, 2008. (Pubitemid 351663621)
32. Kaludercic N, Takimoto E, Nagayama T, Feng N, Lai EW, Bedja D, Chen K, Gabrielson KL, Blakely RD, Shih JC, Pacak K, Kass DA, Di Lisa F, Paolocci N. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload. Circ Res 106: 193-202.
33. Kannankeril PJ, Goldberger JJ. Parasympathetic effects on cardiac electrophysiology during exercise and recovery. Am J Physiol Heart Circ Physiol 282: H2091-H2098, 2002.
34. Keller NR, Diedrich A, Appalsamy M, Miller LC, Caron MG, McDonald MP, Shelton RC, Blakely RD, Robertson D. Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Neuroscience 139: 931-946, 2006.
35. Kuhar MJ, Murrin LC. Sodium-dependent, high affinity choline uptake. J Neurochem 30: 15-21, 1978.
36. La Rovere M. Baroreceptor sensitivity and heart rate variability in the identification of patients at risk for life threatening arrhythmias. Implications for clinical trials. Circulation 94: 2027-2077, 2001.
37. La Rovere MT, Pinna GD, Raczak G. Baroreflex sensitivity: measurement and clinical implications. Ann Noninvasive Electrocardiol 13: 191-207, 2008. (Pubitemid 351569510)
38. 2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am J Physiol Heart Circ Physiol 294: H810-H820, 2008.
39. Lanza GA, Fox K, Crea F. Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing. Adv Cardiol 43: 1-16, 2006.
40. Lefkowitz RR, Koch WJ. Neurotransmission: the autonomic and somatic motor nervous systems. In: Goodman & Gilman's The Pharmacologic Basis of Therapeutics, edited by Hardman JG, Limbird LE, Gilman AG. New York: McGraw-Hill, 1996, p. 105-139.
41. Li B, Duysen EG, Volpicelli-Daley LA, Levey AI, Lockridge O. Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice. Pharmacol Biochem Behav 74: 977-986, 2003. (Pubitemid 36351661)
42. Lin M, Liu R, Gozal D, Wead WB, Chapleau MW, Wurster R, Cheng ZJ. Chronic intermittent hypoxia impairs baroreflex control of heart rate but enhances heart rate responses to vagal efferent stimulation in anesthetized mice. Am J Physiol Heart Circ Physiol 293: H997-H1006, 2007.
43. Lindmar R, Loffelholz K, Weide W, Witzke J. Neuronal uptake of choline following release of acetylcholine in the perfused heart. J Pharmacol Exp Ther 215: 710-715, 1980.
44. Lombardi F. Heart rate variability in the early hours of an acute myocardial infarction. Am J Cardiol 77: 1037-1044, 1996. (Pubitemid 26183716)
45. Ma X, Abboud FM, Chapleau MW. Analysis of afferent, central, and efferent components of the baroreceptor reflex in mice. Am J Physiol Regul Integr Comp Physiol 283: R1033-R1040, 2002.
46. Maire JC, Wurtman RJ. Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum. J Physiol 80: 189-195, 1985.
47. 3H)acetylcholine release. J Neurochem 29: 681-687, 1977.
48. Neumann SA, Lawrence EC, Jennings JR, Ferrell RE, Manuck SB. Heart rate variability is associated with polymorphic variation in the choline transporter gene. Psychosom Med 67: 168-171, 2005.
49. Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I. Identification and characterization of the high-affinity choline transporter. Nat Neurosci 3: 120-125, 2000.
50. Okuda T, Okamura M, Kaitsuka C, Haga T, Gurwitz D. Single nucleotide polymorphism of the human high affinity choline transporter alters transport rate. J Biol Chem 277: 45315-45322, 2002.
51. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118: 863-871, 2008.
52. Palatini P. Elevated heart rate as a predictor of increased cardiovascular morbidity. J Hypertens Suppl 17: S3-S10, 1999.
53. Palatini P, Julius S. Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens 26: 637-644, 2004.
54. Pieper SJ. Heart rate variability: technique and investigational applications in cardiovascular medicine. Mayo Clin Proc 70: 955-964, 1995.
55. Pierpont GL, Stolpman DR, Gornick CC. Heart rate recovery post-exercise as an index of parasympathetic activity. J Auton Nerv Syst 80: 169-174, 2000. (Pubitemid 30227502)
56. Reed D, McGee D, Yano K. Biological and social correlates of blood pressure among Japanese men in Hawaii. Hypertension 4: 406-414, 1982.
57. Ribeiro FM, Pinthong M, Black SA, Gordon AC, Prado VF, Prado MA, Rylett RJ, Ferguson SS. Regulated recycling and plasma membrane recruitment of the high-affinity choline transporter. Eur J Neurosci 26: 3437-3448, 2007.
58. Rottman JN, Ni G, Khoo M, Wang Z, Zhang W, Anderson ME, Madu EC. Temporal changes in ventricular function assessed echocardiographically in conscious and anesthetized mice. J Am Soc Echocardiogr 16: 1150-1157, 2003.
59. Routledge HC. Heart rate variability-a therapeutic target? J Clin Pharm Ther 27: 85-92, 2002.
60. Schwartz PJ, Zaza A, Pala M, Locati E, Beria G, Zanchetti A. Baroreflex sensitivity and its evolution during the first year after myocardial infarction. J Am Coll Cardiol 12: 629-636, 1988.
61. Smith LL, Kukielka M, Billman GE. Heart rate recovery after exercise: a predictor of ventricular fibrillation susceptibility after myocardial infarction. Am J Physiol Heart Circ Physiol 288: H1763-H1769, 2005. (Pubitemid 40418002)
62. Soares PP, Porto CS, Abdalla FM, De La Fuente RN, Moreira ED, Krieger EM, Irigoyen MC. Effects of rat sinoaortic denervation on the vagal responsiveness and expression of muscarinic acetylcholine receptors. J Cardiovasc Pharmacol 47: 331-336, 2006.
63. Syed F, Diwan A, Hahn HS. Murine echocardiography: a practical approach for phenotyping genetically manipulated and surgically modeled mice. J Am Soc Echocardiogr 18: 982-990, 2005.
64. Thayer JFL, Richard D. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychol 74: 224-242, 2007.
65. Tsutsumi T, Ide T, Yamato M, Kudou W, Andou M, Hirooka Y, Utsumi H, Tsutsui H, Sunagawa K. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc Res 77: 713-721, 2008.
66. Umana E, Solares CA, Alpert MA. Tachycardia-induced cardiomyopathy. Am J Med 114: 51-55, 2003.
67. Vaseghi M, Shivkumar K. The role of the autonomic nervous system in sudden cardiac death. Prog Cardiovasc Dis 50: 404-419, 2008. (Pubitemid 351637603)
68. Vecoli C, Paolocci N. When the heart sleeps . . . is the vagus resetting the myocardial "redox clock"? Cardiovasc Res 77: 609-611, 2008.
69. Weber KT, Brilla CG, Janicki JS. Myocardial remodeling and pathologic hypertrophy. Hosp Pract (Off Ed) 26: 73-80, 1991.
70. Wickman K, Nemec J, Gendler SJ, Clapham DE. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20: 103-114, 1998.